section_path: Antibiotic pipeline/Replenishing the antibiotic pipeline and developing other new therapies
section_name: Replenishing the antibiotic pipeline and developing other new therapies
paragraph_text: Replenishing the antibiotic pipeline and developing other new therapies
  
  Because antibiotic-resistant bacterial strains continue to emerge and spread, there is a constant need to develop new antibacterial treatments. Current strategies include traditional chemistry-based approaches such as natural product -based drug discovery, newer chemistry-based approaches such as drug design, traditional biology-based approaches such as immunoglobulin therapy, and experimental biology-based approaches such as phage therapy, fecal microbiota transplants, antisense RNA -based treatments, and CRISPR-Cas9 -based treatments.